Next Article in Journal
A Marine Anticancer Cinnamyloxyl Derivative with Unique Binding Sites at Carbonic Anhydrase IX (CAIX) Inhibits Adenocarcinomic A549 Cells
Next Article in Special Issue
Potential Adjunctive Effects of Quercetin–Curcumin Co-Supplementation in Adults with Mild-to-Moderate Long COVID: Results from a Pragmatic Exploratory Real-World Clinical Study
Previous Article in Journal
Prediction of Targets and Mechanisms of Top Ten Core “Food–Medicine Homologous Traditional Chinese Medicines” in Delaying Vascular Aging: An Integrative Computational Study
Previous Article in Special Issue
Neuroprotective Effects of Fluoxetine Derivative 4-[3-Oxo-3-(2-trifluoromethyl-phenyl)-propyl]-morpholinium Chloride (OTPM) as a Potent Modulator of Motor Deficits and Neuroinflammatory Pathways in LPS-Induced BV-2 Microglial Cells and MPTP-Induced Parkinsonian Models
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Metabolic Reprogramming by Andrographolide: Enhanced Pentose Phosphate Pathway and Antioxidant Capacity in Cortical Astrocytes

by
Pedro Cisternas
1,*,
Paulina Ormazabal
2,
Camila Gherardelli
3,
Marianela Bastías-Pérez
1,4,
Jose Brito-Valenzuela
5 and
Nibaldo C. Inestrosa
3,6,*
1
Núcleo de Investigación en Nutrición y Ciencias Alimentarias (NINCAL), Facultad de Salud y Ciencias Sociales, Universidad de Las Américas, Santiago 7500658, Chile
2
Facultad de Ciencias para el Cuidado de la Salud, Universidad San Sebastián, Lota 2465, Providencia, Santiago 7510157, Chile
3
Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Av. Bernardo O’Higgins 340, Santiago 8331150, Chile
4
Centro de Investigación Biomédica en Red (CIBER) de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), E-28029 Madrid, Spain
5
Departamento de Obstetricia y Puericultura, Facultad de Medicina, Universidad de Concepción, Concepción 4030000, Chile
6
Centro de Excelencia en Biomedicina de Magallanes (CEBIMA), Escuela de Medicina, Universidad de Magallanes, Punta Arenas 6200000, Chile
*
Authors to whom correspondence should be addressed.
Pharmaceuticals 2026, 19(1), 133; https://doi.org/10.3390/ph19010133
Submission received: 13 November 2025 / Revised: 30 December 2025 / Accepted: 9 January 2026 / Published: 12 January 2026

Abstract

Background/Objectives: Astrocytes are key regulators of brain energy homeostasis, integrating glucose metabolism with antioxidant support for neuronal function. Dysregulation of these processes contributes to neurodegenerative diseases, including Alzheimer’s disease. Andrographolide, a bioactive diterpenoid from Andrographis paniculata, has been reported to exert neuroprotective effects through the modulation of Wnt/β–catenin signaling and neuronal metabolism; however, its actions on astrocytic metabolic pathways remain insufficiently characterized. Methods: Here, we investigated the effects of andrographolide on metabolic and redox parameters in primary mouse cortical astrocytes. Results: Andrographolide increased glucose uptake and antioxidant capacity without affecting AMPK activation or the activity of core glycolytic enzymes. Instead, it selectively enhanced glucose-6-phosphate dehydrogenase activity, promoting glucose flux through the pentose phosphate pathway in a partially Wnt-dependent manner. This metabolic reprogramming was associated with increased NADPH availability and glutathione levels, together with a reduced ATP/ADP ratio, consistent with a shift toward redox maintenance rather than maximal energy production. Conclusions: Collectively, these findings highlight astrocytic metabolic plasticity as a relevant and underexplored target of andrographolide and support the concept that natural compounds can enhance brain resilience by modulating glial redox metabolism.
Keywords: astrocytes; andrographolide; glucose metabolism; neuroprotection; Alzheimer disease astrocytes; andrographolide; glucose metabolism; neuroprotection; Alzheimer disease
Graphical Abstract

Share and Cite

MDPI and ACS Style

Cisternas, P.; Ormazabal, P.; Gherardelli, C.; Bastías-Pérez, M.; Brito-Valenzuela, J.; Inestrosa, N.C. Metabolic Reprogramming by Andrographolide: Enhanced Pentose Phosphate Pathway and Antioxidant Capacity in Cortical Astrocytes. Pharmaceuticals 2026, 19, 133. https://doi.org/10.3390/ph19010133

AMA Style

Cisternas P, Ormazabal P, Gherardelli C, Bastías-Pérez M, Brito-Valenzuela J, Inestrosa NC. Metabolic Reprogramming by Andrographolide: Enhanced Pentose Phosphate Pathway and Antioxidant Capacity in Cortical Astrocytes. Pharmaceuticals. 2026; 19(1):133. https://doi.org/10.3390/ph19010133

Chicago/Turabian Style

Cisternas, Pedro, Paulina Ormazabal, Camila Gherardelli, Marianela Bastías-Pérez, Jose Brito-Valenzuela, and Nibaldo C. Inestrosa. 2026. "Metabolic Reprogramming by Andrographolide: Enhanced Pentose Phosphate Pathway and Antioxidant Capacity in Cortical Astrocytes" Pharmaceuticals 19, no. 1: 133. https://doi.org/10.3390/ph19010133

APA Style

Cisternas, P., Ormazabal, P., Gherardelli, C., Bastías-Pérez, M., Brito-Valenzuela, J., & Inestrosa, N. C. (2026). Metabolic Reprogramming by Andrographolide: Enhanced Pentose Phosphate Pathway and Antioxidant Capacity in Cortical Astrocytes. Pharmaceuticals, 19(1), 133. https://doi.org/10.3390/ph19010133

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop